SASKATOON, Saskatchewan--(BUSINESS WIRE)--CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed”) announces that, effective November 17, 2017, Mr. Rob Duguid has resigned from the Board of Directors. The Company thanks Mr. Duguid for his service on the board since 2001 and wishes him well in the future.
https://www.businesswire.com/news/home/20171120005475/en/